A proteomic platform to identify off-target proteins associated with therapeutic modalities that induce protein degradation or gene silencing

Abstract Novel modalities such as PROTAC and RNAi have the ability to inadvertently alter the abundance of endogenous proteins. Currently available in vitro secondary pharmacology assays, which evaluate off-target binding or activity of small molecules, do not fully assess the off-target effects of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Liu, Ye Zhang, Lucas D. Ward, Qinghong Yan, Tanggis Bohnuud, Rocio Hernandez, Socheata Lao, Jing Yuan, Fan Fan
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/bceb4a3a9b72451bb8dd1f5b780cc4d7
Tags: Add Tag
No Tags, Be the first to tag this record!